GGrantIndex
← Leaderboards

Warren J Manning

Beth Israel Deaconess Medical Center

$7,083,412
Attributed
$7,083,412
Total exposure
6
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $863.4K · FY200512
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$7,083,412 · 6

By mechanism

R01$6,503,040 · 2
M01$387,832 · 3
S10$192,540 · 1

Top collaborators

No co-investigators on record.

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectClinical ResearchMagnetic Resonance ImagingDiagnosis Design /EvaluationObesityAtherosclerosisBioimaging /Biomedical ImagingDisease /Disorder Proneness /RiskHeart Imaging /Visualization /ScanningHormone Regulation /Control MechanismAcute Phase ProteinHeart Disorder DiagnosisAngiocardiographyHeart FunctionCoronary DisorderCardiovascular Disorder DiagnosisCardiovascular Imaging /VisualizationDiagnosis Quality /StandardAdipocytesBiochemicalAmericanAge DifferenceAcute-Phase ProteinsBlood Circulation

Grant awards (22)

Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$799,242
R01 · FY2012 · HL · contact PI
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$823,001
R01 · FY2010 · HL · contact PI
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$823,860
R01 · FY2009 · HL · contact PI
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$863,379
R01 · FY2008 · HL · contact PI
Cardiac MR of Subclin CVD: Impact of Age$397,079
R01 · FY2005 · HL
Cardiac MR of Subclin CVD: Impact of Age$397,080
R01 · FY2004 · HL
Cardiac MR of Subclin CVD: Impact of Age$817,061
R01 · FY2003 · HL
Cardiac MR of Subclin CVD: Impact of Age$770,355
R01 · FY2002 · HL
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2002 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2002 · RR
Cardiac MR of Subclin CVD: Impact of Age$811,983
R01 · FY2001 · HL
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2001 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2001 · RR
IMPACT OF OLESTRA ON ANTICOAGULATION IN PATIENTS W/ WARFARIN$193,916
M01 · FY2000 · RR
IMPACT OF OLESTRA ON ANTICOAGULATION IN PATIENTS W/ WARFARIN$193,916
M01 · FY2000 · RR
SMALL ANIMAL ECHOCARDIOGRAPHIC IMAGING SYSTEMS$192,540
S10 · FY2000 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2000 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2000 · RR
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2000 · RR
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2000 · RR
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2000 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2000 · RR